Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 224

Results For "ABI"

3121 News Found

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


Intuitive launches My Intuitive App
Digitisation | April 11, 2022

Intuitive launches My Intuitive App

The app serves as a single, integrated, personalized customer platform for da Vinci surgeons


Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
News | April 11, 2022

Israel’s TAU breakthrough offers new hope to help people with paralysis walk again

Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein


Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle


Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility
Diagnostic Center | April 11, 2022

Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility

Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics


AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre
News | April 10, 2022

AstraZeneca Chennai centre repositioned as Global Innovation and Technology Centre

With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country


New research on drug-induced gene signatures for colorectal cancer patients
Biotech | April 10, 2022

New research on drug-induced gene signatures for colorectal cancer patients

Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes